BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 21787113)

  • 21. Expression of the ETS transcription factor ELF3 in the retinal pigment epithelium.
    Jobling AI; Fang Z; Koleski D; Tymms MJ
    Invest Ophthalmol Vis Sci; 2002 Nov; 43(11):3530-7. PubMed ID: 12407165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ets protein Elf-1 bidirectionally suppresses transcriptional activities of the tumor suppressor Tsc2 gene and the repair-related Nth1 gene.
    Honda S; Kobayashi T; Kajino K; Urakami S; Igawa M; Hino O
    Mol Carcinog; 2003 Jul; 37(3):122-9. PubMed ID: 12884363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P; Ye L; Yang Y; Jiang WG
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigenetic alterations of Krüppel-like factor 4 and its tumor suppressor function in renal cell carcinoma.
    Li H; Wang J; Xiao W; Xia D; Lang B; Yu G; Guo X; Guan W; Wang Z; Hu Z; Liu J; Ye Z; Xu H
    Carcinogenesis; 2013 Oct; 34(10):2262-70. PubMed ID: 23722653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Loss of type III transforming growth factor-beta receptor expression is due to methylation silencing of the transcription factor GATA3 in renal cell carcinoma.
    Cooper SJ; Zou H; Legrand SN; Marlow LA; von Roemeling CA; Radisky DC; Wu KJ; Hempel N; Margulis V; Tun HW; Blobe GC; Wood CG; Copland JA
    Oncogene; 2010 May; 29(20):2905-15. PubMed ID: 20208565
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Loss of HNF1alpha function in human renal cell carcinoma: frequent mutations in the VHL gene but not the HNF1alpha gene.
    Lemm I; Lingott A; Pogge v Strandmann E; Zoidl C; Bulman MP; Hattersley AT; Schulz WA; Ebert T; Ryffel GU
    Mol Carcinog; 1999 Apr; 24(4):305-14. PubMed ID: 10326868
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Frequent expression of Bcl-2 in renal-cell carcinomas carrying wild-type p53.
    Tomita Y; Bilim V; Kawasaki T; Takahashi K; Okan I; Magnusson KP; Wiman KG
    Int J Cancer; 1996 May; 66(3):322-5. PubMed ID: 8621251
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Functional significance of Wnt inhibitory factor-1 gene in kidney cancer.
    Kawakami K; Hirata H; Yamamura S; Kikuno N; Saini S; Majid S; Tanaka Y; Kawamoto K; Enokida H; Nakagawa M; Dahiya R
    Cancer Res; 2009 Nov; 69(22):8603-10. PubMed ID: 19887605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. NDRG2 is involved in the oncogenic properties of renal cell carcinoma and its loss is a novel independent poor prognostic factor after nephrectomy.
    Liang ZL; Kang K; Yoon S; Huang SM; Lim JS; Kim JM; Lim JS; Lee HJ
    Ann Surg Oncol; 2012 Aug; 19(8):2763-72. PubMed ID: 22246425
    [TBL] [Abstract][Full Text] [Related]  

  • 30. MDM2 interacts with NME2 (non-metastatic cells 2, protein) and suppresses the ability of NME2 to negatively regulate cell motility.
    Polanski R; Maguire M; Nield PC; Jenkins RE; Park BK; Krawczynska K; Devling T; Ray-Sinha A; Rubbi CP; Vlatkovic N; Boyd MT
    Carcinogenesis; 2011 Aug; 32(8):1133-42. PubMed ID: 21504894
    [TBL] [Abstract][Full Text] [Related]  

  • 31. mRNA expression profiles of methylated APAF-1 and DAPK-1 tumor suppressor genes uncover clear cell renal cell carcinomas with aggressive phenotype.
    Christoph F; Hinz S; Kempkensteffen C; Schostak M; Schrader M; Miller K
    J Urol; 2007 Dec; 178(6):2655-9. PubMed ID: 17945286
    [TBL] [Abstract][Full Text] [Related]  

  • 32. High Jagged1 expression predicts poor outcome in clear cell renal cell carcinoma.
    Wu K; Xu L; Zhang L; Lin Z; Hou J
    Jpn J Clin Oncol; 2011 Mar; 41(3):411-6. PubMed ID: 21062756
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Vitamin D3 triggers antitumor activity through targeting hedgehog signaling in human renal cell carcinoma.
    Dormoy V; Béraud C; Lindner V; Coquard C; Barthelmebs M; Brasse D; Jacqmin D; Lang H; Massfelder T
    Carcinogenesis; 2012 Nov; 33(11):2084-93. PubMed ID: 22843547
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transforming growth factor alpha is a target for the von Hippel-Lindau tumor suppressor.
    Knebelmann B; Ananth S; Cohen HT; Sukhatme VP
    Cancer Res; 1998 Jan; 58(2):226-31. PubMed ID: 9443397
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Up-regulation of hypoxia-inducible factor 2alpha in renal cell carcinoma associated with loss of Tsc-2 tumor suppressor gene.
    Liu MY; Poellinger L; Walker CL
    Cancer Res; 2003 May; 63(10):2675-80. PubMed ID: 12750296
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BMP-2 inhibits tumor growth of human renal cell carcinoma and induces bone formation.
    Wang L; Park P; Zhang H; La Marca F; Claeson A; Than K; Rahman S; Lin CY
    Int J Cancer; 2012 Oct; 131(8):1941-50. PubMed ID: 22275155
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Downregulation of Cap43 gene by von Hippel-Lindau tumor suppressor protein in human renal cancer cells.
    Masuda K; Ono M; Okamoto M; Morikawa W; Otsubo M; Migita T; Tsuneyoshi M; Okuda H; Shuin T; Naito S; Kuwano M
    Int J Cancer; 2003 Jul; 105(6):803-10. PubMed ID: 12767066
    [TBL] [Abstract][Full Text] [Related]  

  • 38. ETS transcription factor ELF5 induces lumen formation in a 3D model of mammary morphogenesis and its expression is inhibited by Jak2 inhibitor TG101348.
    Chean J; Chen CJ; Shively JE
    Exp Cell Res; 2017 Oct; 359(1):62-75. PubMed ID: 28800960
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dual roles for coactivator activator and its counterbalancing isoform coactivator modulator in human kidney cell tumorigenesis.
    Kang YK; Schiff R; Ko L; Wang T; Tsai SY; Tsai MJ; O'Malley BW
    Cancer Res; 2008 Oct; 68(19):7887-96. PubMed ID: 18829545
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epithelial Expression of Human ABO Blood Group Genes Is Dependent upon a Downstream Regulatory Element Functioning through an Epithelial Cell-specific Transcription Factor, Elf5.
    Sano R; Nakajima T; Takahashi Y; Kubo R; Kobayashi M; Takahashi K; Takeshita H; Ogasawara K; Kominato Y
    J Biol Chem; 2016 Oct; 291(43):22594-22606. PubMed ID: 27587399
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.